Back to today’s briefing

Story perspectives

Genetic Evidence Boosts Drug Development Success Rates

9/27/2025

48 6

Summary

Story summary

Ferguson emphasizes genetic evidence in drug development, citing a 2.6-fold success rate for programs with backing.
AGD aims to improve drug discovery by integrating diverse genomic data and electronic medical records (EMRs) from multiple populations, especially African Americans.
AGD collaborates with biopharma to address historical biases in clinical research.
Illumina will add multi-omic data; funding comes from Illumina and partners.

1 of 1

Story summary

Ferguson emphasizes genetic evidence in drug development, citing a 2.6-fold success rate for programs with backing.
AGD aims to improve drug discovery by integrating diverse genomic data and electronic medical records (EMRs) from multiple populations, especially African Americans.
AGD collaborates with biopharma to address historical biases in clinical research.
Illumina will add multi-omic data; funding comes from Illumina and partners.